TMS for OCD: What to Expect and How to Get Started

In 2019, a multicenter randomized controlled trial published in The American Journal of Psychiatry found that targeted transcranial magnetic stimulation significantly reduced OCD symptom severity compared to sham treatment. Patients in the active treatment group showed meaningful improvements on the Yale-Brown Obsessive Compulsive Scale — the gold standard measure used in OCD research.

That study was not an outlier.

Multiple meta-analyses published in Journal of Psychiatric Research and Brain Stimulation have since concluded that repetitive TMS (rTMS) can produce moderate but clinically meaningful reductions in OCD symptoms, particularly when stimulation targets prefrontal circuits involved in cognitive control and emotional regulation.

The takeaway is straightforward:
OCD is not only treatable through therapy and medication. There is growing, peer-reviewed evidence that targeted neuromodulation can reduce symptom intensity in some patients — especially when other treatments have provided incomplete relief.

Why TMS makes sense for OCD

OCD is increasingly understood as a disorder of dysregulated brain circuits, particularly those connecting the prefrontal cortex with deeper regions involved in threat detection and habit formation. When these circuits become overactive, intrusive thoughts feel urgent and compulsions feel necessary.

Repetitive TMS works by delivering focused magnetic pulses to specific cortical regions. Over time, this stimulation can help recalibrate overactive pathways and strengthen regulatory control.

It does not erase intrusive thoughts. It does not eliminate anxiety overnight. What it can do, according to both research and clinical experience, is reduce the intensity and rigidity of obsessive-compulsive patterns.

For some patients, that shift is enough to make therapy more effective and daily functioning more manageable.

What the research shows in practical terms

Across controlled trials and systematic reviews, rTMS has been associated with:

• Measurable reductions in OCD symptom scores
• Improved cognitive flexibility
• Better tolerance of distress during behavioral therapy
• A favorable safety and tolerability profile

Side effects are typically mild and limited to temporary scalp discomfort or headache.

Importantly, rTMS is noninvasive and does not involve systemic medication.

What TMS can realistically help with

TMS is not a replacement for Exposure and Response Prevention (ERP), which remains the most evidence-based psychotherapy for OCD.

However, patients often report that after TMS:

• Compulsions feel less urgent
• Intrusive thoughts feel less “sticky”
• Anxiety feels more manageable
• They are better able to engage in ERP exercises

In other words, TMS may reduce the volume enough for meaningful therapeutic work to occur.

What to expect during treatment

Treatment is delivered in an outpatient setting. Patients remain awake and resume normal activities immediately afterward.

A typical course includes:

• Five sessions per week
• Four to six weeks of treatment
• Sessions lasting approximately 20–40 minutes

Before beginning, a structured psychiatric evaluation reviews diagnosis, treatment history, symptom severity, and insurance eligibility.

Who may consider TMS for OCD

TMS may be appropriate when:

• ERP has provided incomplete relief
• Multiple medication trials have not produced sufficient benefit
• Medication side effects limit optimization
• OCD significantly interferes with work, school, or relationships

For individuals with co-occurring depression, TMS may also provide broader mood stabilization.

Getting started

Begin with a consultation. We review your OCD symptoms, prior treatments, and determine whether rTMS may be an appropriate adjunct to your care. If indicated, treatment is integrated with ongoing psychotherapy, not positioned as a replacement.

Serving Castro Valley, Hayward, and the East Bay

For patients in Castro Valley, Hayward, San Leandro, Fremont, Union City, Dublin, and surrounding East Bay communities, we provide outpatient psychiatric evaluation and evidence-based rTMS locally.

We work with major insurers and clarify eligibility and expected costs before treatment begins.

If OCD symptoms remain disruptive despite therapy or medication, contact our office to schedule an evaluation and discuss next steps.

Citations

1. Carmi, L., et al. (2019). Efficacy and safety of transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized controlled trial.
   American Journal of Psychiatry, 176(11), 931–938.
2. Rehn, S., et al. (2018). Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials.
   Journal of Psychiatric Research, 107, 94–103.
3. Trevizol, A. P., et al. (2016). Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: An updated systematic review and meta-analysis.
   Journal of ECT, 32(4), 262–266.
4. Rossi, S., et al. (2021). Safety, ethical considerations, and application guidelines for transcranial magnetic stimulation.
   Clinical Neurophysiology, 132(1), 269–306.

Scientific Disclaimer

This article is for educational purposes only and does not constitute medical advice. Repetitive Transcranial Magnetic Stimulation (rTMS) is FDA-cleared for Major Depressive Disorder. Its use in OCD may be considered adjunctive and, in some cases, off-label depending on protocol and individual presentation. TMS does not replace evidence-based psychotherapy such as Exposure and Response Prevention (ERP). Treatment decisions should be made in consultation with qualified healthcare professionals following comprehensive evaluation.